BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3980104)

  • 21. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello MJ; Alexander JB; Wisdom C; Camishion RC
    Crit Care Med; 1990 Nov; 18(11):1227-30. PubMed ID: 1699704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
    Cleman M; Jaffee CC; Wohlgelernter D
    Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage.
    Karn KE; Ogburn PL; Julian T; Cerra FB; Hammerschmidt DE; Vercellotti G
    Obstet Gynecol; 1985 Jan; 65(1):127-30. PubMed ID: 3871250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
    J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
    Biro GP
    Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
    Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.
    Castro O; Nesbitt AE; Lyles D
    Am J Hematol; 1984 Jan; 16(1):15-21. PubMed ID: 6695906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
    Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Fluosol-DA 20% in prehospital resuscitation.
    Elliott LA; Ledgerwood AM; Lucas CE; McCoy LE; McGonigal M; Sullivan MW
    Crit Care Med; 1989 Feb; 17(2):166-72. PubMed ID: 2914450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Fluosol-DA 20% and oxygen on response of C57BL/6 mice to whole-body irradiation.
    Waldow SM; Lustig RA; Brass-Marlow EL; Nunno MP; Holst RJ; Wallner PE
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):665-8. PubMed ID: 2211213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
    Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
    J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.